If You’d Invested $10,000 in Micron After Its IPO, Here’s How Much You Would Have Now.
You would have scored a spectacular win.
Should Social Security’s Insolvency Change Your Retirement Plans?
The program’s future could influence yours.
Kevin Warsh’s Inflation Testimony Came as Traders Priced an 86% Chance of a Fed Rate Hold
Interest rates seem likely to stay constant or go up.
Scientists found mystery bacteria inside one of the ocean’s most elusive whales
Scientists studying decades of pygmy sperm whale strandings have uncovered three previously unknown types of Helicobacter bacteria hiding in the animals’ stomachs. All four infected whales showed serious digestive damage, including inflammation, ulcers…
New molecular map reveals how the flu virus hijacks human cells
Scientists uncovered how influenza A commandeers human cells, including a surprising strategy that dissolves tiny structures in the nucleus and releases proteins the virus may use to reproduce. The detailed molecular map could reveal new drug targets a…
This food compound may help vaccines work better in older adults
A naturally occurring compound found in foods such as wheat germ, mushrooms, and aged cheese may help older adults build stronger protection after vaccination. In a small pilot trial, researchers gave spermidine supplements to adults over 65 following …
Dying Sun-like stars may kick themselves through space
Dying Sun-like stars may not fade away quietly. As blobs of gas erupt unevenly from their swollen surfaces, each burst gives the star a tiny push in the opposite direction. Thousands of these random kicks could eventually break apart distant stellar pa…
New quantum gravity theory links entropy, dark energy, and life
A new theoretical study offers a possible explanation for how the Universe can grow more complex without violating the second law of thermodynamics. Using a quantum gravity framework called Gravity from Entropy, mathematician Ginestra Bianconi found th…
New antibody drug stops aggressive prostate cancer from spreading
Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism could open the door to a safer new treatment for adv…